Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
He says that he is long, but he doesn’t talk AS IF he is long. At times that describes several people, occasionally me, too.
This isn’t an emergency, there will always be plenty of time for him to get pessimistic later.
Could the FDA be capricious enough to change their mind and require another trial ? Yes. Has Nader consistently described the process of how the trial could become pivotal ? Yes. Nader appears to be saying nothing new or different.
But dang, I wonder if I could possibly give a better interview.
Hello .... ?
Yes, anyone can open an Ameritrade account and purchase CYDY. But generally, Big Money does not buy any OTC.
The market won’t suspect the science is proven until the BLA is submitted. Hence the nap.
There’s been a long, slow, irregular slide downward for the last few years. It will take sustained multi Mill share days to boost us up from where we are now. I’m not gonna try my patience hoping for it. I will take a fall and winters nap, and hopefully spring will come as it is supposed to.
It going to be a couple quarters before we make it up to that kind of price.
Not necessarily a relative; didn’t notice a physical resemblance. Everything in Nicks resume was southeast based, and Nader resume is northwest based. Not a disproof, but not too likely.
Terd, you know about the need for toilet paper. You need a wipe
Stop calling me Shirley !
Yes, Pestell is a very big deal. BUT .... his company hasn’t officially been bought yet. So, financially nothing has changed yet.
Arizona ?
Yes, But the time at which all this comes together is being pushed into the future by insufficient funding. Harrumph !
Yes, I think if we could, each and every one of us would be there.
Wishing don’t make it so. It takes discipline, whether you’re a long term investor, or a short term trader. I’m not sure I have that anymore. Perhaps I wasn’t hanging onto shares of a company, but merely holding onto a dream. I still believe that dream will be realized, but one OUGHT to invest in a company. I think I wasn’t.
Intellectual property is difficult to splice along indicational lines. National lines; sure ! But I think that has been done before.
Can retail only buying buck that multi year trend ? No. At some point .... whenever that is, larger investors will come in to overcome that. Again, whenever that is.
Perhaps at (or before) the time of CYDY’s purchase, there could be a spinoff of ProstaGene.
Maybe not; A lot of Gilead’s brains have left.
“ The addition of a tycoon investor and a world renown cancer expert to the CYDY board indicates activity as a minimum. Neither of these gentlemen would be willing to give up their time to deal with a company of this stature unless they saw a much bigger play. The current market capitalization of CYDY is only $105 million. Once approved as just a combination therapy BioVid Market Research estimates sales of $1.2 billion assuming 49,000 patients. If there is a label expansion to monotherapy that number rises to $3.8 billion. The company is trading at less than 10% of BioVids projected value 7months from now with a BLA Application filed”
A 6 employee company CANT go it alone.
I may be wrong in thinking there might be some PR after this event.
The Lawman posted :
Paulson Meet and Greet Next Wednesday Redwood City.
Drs. Pourhassan and Pestell to host.
Appears Dr. Pestell is fully onboard (although not on board).
LM
So meeting Wed night and PR Thursday morning ?
This board has more shares than all the institutions put together. How long will that remain true ? End of the year ?
Willis Invst Counsel added 45K shares for a total of 0.13%.
Finesand estimated about one-fifth that much in revenue. It says market potential.
Finesand had estimates not NEARLY that high (although I would have thought higher)
Good a more mainstream venue, reaching more people. The market potential is $5 Bill with Pro140 getting a small fraction of that, but multiply by 3 X revenue and you still have a large market value.
Ok, thanks for the correction.
Didn’t you get the impression (as I did) that pivotal status would more than likely be agreed to by FDA, or is Nader applying his usual optimism ?
Nader said the existing trail could be converted to pivotal; not start another one.
So mono approval is 2021 ?
There would be nothing to fear of an R/S if that would be done in accompany with the proper news. A big licensing deal, $100 Million financing, BLA submittal ... I have NO idea what the BLEEP Nader was thinking this spring. On the OTC, we are a penny stock until next year. Or until one of those things happen; Even then one buck seems likely but not guaranteed. That’s part of the reason I sold some this summer, we are GUARANTEED to be grossly undervalued while on OTC.
I don’t think the article said anything about cancer, GvHD, MS, or Dr Pestell
But I think all of that is now being mentioned in the comments !
You are not alone in that. For 2 years I have had the occasional thought that there was a conspiracy against Pro140. It takes longer and longer to dispel those thoughts, but they eventually go.
“Klump pulls a money rabbit out of his magical hat”
“Now that’s something we’ll REALLY like” - - Rocky the Squirrel
I don’t think that’s right. Chump, I was able to find about 2,000 phase 3 metastatic cancer trials at clinical trials.gov
Already tried that earlier this year and it didn’t really work.